Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)
Clinical trial NCT04314531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04314531
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2025-06-04
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.